Skip to main content

Table 2 PCT and P-SEP values of present HD patient and previously reported HD patients without infection

From: A hemodialysis patient with Mycobacterium avium complex pericarditis in which remarkable presepsin elevation was not accompanied by procalcitonin elevation

N

Assay

Serum PCT, ng/mL

Ref.

N

Assay

Plasma P-SEP, pg/mL

Ref.

123

ECLIA

median 0.23

13

17

CLEIA

median (IQR) 1434 (1171–1891)

19

89

ECLIA

mean ± SD 0.23 ± 0.25

median(range) 0.17 (9.05–1.73)

14

10

CLEIA

median (IQR) 1305 (814–1858)

20

20

ELFA

mean ± SD 0.50 ± 0.49

15

20

CLEIA

median (IQR) 1510 (1205–1810)

21

48

ECLIA

median (5th–95th percentile) 0.17 (0.090–0.824)

16

98

CLEIA

mean ± SD 1327 ± 914

22

61

ECLIA

mean ± SD 0.20 ± 0.14

17

13

CLEIA

median (IQR) 1160 (1070–1400)

12

23

IFA

median (95% CI) 0.79 (0.45–0.99)

18

    
 

CLEIA

0.17–0.35

  

CLEIA

19000–12100 (2019/1~2019/9)

 
  1. PCT procalcitonin, P-SEP presepsin, HD hemodialysis, MAC Mycobacterium avium complex, ECLIA electrochemiluminescence immunoassay, ELFA enzyme-linked fluorescent assay, IFA immunofluorescence assay, SD standard deviation, CI confidence interval, IQR interquartile range
  2. The data of the last line indicate the PCT and P-SEP values in the present case report. All other values pertain to cases involving HD patients without infection